In response to growing demand for more personalized vacation experiences, Divi Resorts is proud to announce the launch of enhanced all-inclusive package options at Divi Little Bay Beach Resort and ...

Divi Resorts is bringing back its popular Kids Stay & Eat Free program for a limited time! On all-inclusive stays, kids 12 ...

Divi's Labs makes active pharmaceutical ingredients for Entresto for Novartis, which contributes nearly 8% to Hyderabad-based ...

Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, ...

Stock recommendations today include HCLTech, Ola Electric, Kalyan Jewellers, and Sun Pharma as analysts review June quarter ...

AGNC Investment invests solely in mortgage-backed securities (MBS) protected from credit risk by government agencies like ...

Draped in a delicately crafted woolen woven designer bra, Divi Vadthya blends elegance and boldness in this winter-chic look.

Anthem Biosciences’ IPO puts the spotlight on India’s contract drug manufacturing sector, as investor appetite swells and global firms diversify away from China.

The shares of one of India's leading API manufacturers, engaged in the production and export of APIs, intermediates, and ...

Anthem Biosciences is a leading player in the fast growing CRDMO (Contract Research, Development and Manufacturing ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

Anthem Biosciences IPO on Day 2 with moderate success, price band ₹540-570, 35% reserved for retail investors.